All listings for this product
Best-selling in Non-Fiction Books
Save on Non-Fiction Books
- AU $47.34Trending at AU $49.44
- AU $77.99Trending at AU $116.29
- AU $70.14Trending at AU $77.15
- AU $74.58Trending at AU $76.54
- AU $35.45Trending at AU $39.03
- AU $26.74Trending at AU $37.56
- AU $17.67Trending at AU $23.05
About this product
- DescriptionThe desperate need for a vast part of the global population to access better medicines in more certain ways is one of the biggest concerns of the modern era. Pills for the Poorest offers a new perspective on the much-debated issue of the links between intellectual property and access to medication. Using ethgraphic case studies in Djibouti and Ghana, and insights from actor-network theory, it explores the ways in which TRIPs and pharmaceutical patents are translated in the daily practices of those who purchase, distribute, and use (or fail to use) medicines in sub-Saharan Africa. It suggests that focusing on routine practices and the material deployment of intellectual property significantly enriches our understanding of the complex dynamics that animate the field of access to medicines and helps relocate the role of law within those processes. It demonstrates how intellectual property affects access to medicines in ways that are often discreet, indirect and forgotten. By exploring these complex mechanisms, it seeks to ask questions about the modes of actions of pharmaceutical patents, but also, more generally, about the complexity of legal objects.
- Author BiographyEmilie Cloatre is a Senior Lecturer at Kent Law School, University of Kent, UK.
- PrizesWinner of SLSA-Hart Socio-Legal Book Prize 2014.
- Author(s)Emilie Cloatre
- PublisherPalgrave Macmillan
- Date of Publication05/08/2013
- SubjectInternational Law: Professional
- Series TitlePalgrave Macmillan Socio-Legal Studies
- Country of PublicationUnited Kingdom
- ImprintPalgrave Macmillan
- Content Notebiography
- Weight488 g
- Width156 mm
- Height234 mm
- Spine17 mm
This item doesn't belong on this page.
Thanks, we'll look into this.